Medication info
Clopine Tablet (Clopidogrel Bisulfate)

Clopine Tablet (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Hanpoong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201904612 · Approved 2019.07.08 · Insurance code 658106640

Summary

Main use
Treatment of acute coronary syndrome and symptoms of atherosclerosis; prevention of thrombosis in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg once daily administered orally. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. This drug may be taken with or without food.

Ingredients

Manufacturer
Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acute coronary syndrome and symptoms of atherosclerosis; prevention of thrombosis in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular events
  • stroke
  • resistant ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, in patients with acute coronary syndrome who have experienced unstable angina or non-ST elevation myocardial infarction, it improves symptoms associated with atherosclerosis such as cardiovascular-related death, myocardial infarction, and stroke following drug treatment, percutaneous coronary intervention, or coronary artery bypass grafting. Finally, it helps to reduce the risk of stroke and thromboembolism in adults with one or more vascular risk factors when the administration of vitamin K antagonists is not appropriate. In summary, this medication is effective in improving vascular health in patients with various cardiovascular and cerebrovascular diseases and reducing the risk of serious complications.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg once daily administered orally. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. This drug may be taken with or without food.

Precautions

This medication helps prevent the aggregation of platelets, allowing blood to flow more easily. Individuals with a genetic deficiency in the CYP2C19 enzyme may have reduced effectiveness of this medication, in which case treatment options should be reconsidered. Moreover, concurrent use with drugs that increase the activity of the CYP2C19 enzyme may elevate the blood concentration of this medication, increasing the risk of bleeding, so co-administration is not advised. Patients who are allergic to this medication or its components, those with bleeding issues, severe liver dysfunction, those who are breastfeeding, and those with genetic conditions such as lactose intolerance should not take this medication. Caution should be exercised in patients at high risk of bleeding or those with bleeding disorders, and if surgery is planned, the physician should be consulted to discontinue the medication 5 to 7 days prior to the procedure. This medication may increase the likelihood of bleeding when taken with other drugs that also pose bleeding risks, so attention is warranted. Patients should inform the hospital immediately of any bleeding symptoms or unusual signs while taking this medication and regular blood tests are recommended. This medication primarily inhibits platelet function and can prolong bleeding time, which may result in bleeding taking longer than usual to stop. Taking this medication generally does not have a significant effect on driving or operating machinery, but caution is advised as individual responses may vary. While no significant risks to the fetus during pregnancy have been reported, a higher risk of bleeding during delivery may occur, hence discontinuation before childbirth is recommended. In breastfeeding cases, since this medication may pass into breast milk, patients should consult their physician about whether to continue breastfeeding or discontinue the medication. Usage in children is not recommended as safety and efficacy have not been established. The elderly may have reduced physical function leading to increased bleeding risks, so dosage adjustments and monitoring of conditions are necessary. In case of overdose, the risk of bleeding may increase, and immediate medical attention is required as there is no specific antidote; platelet transfusion may be necessary for severe bleeding. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Hemorrhage
  • gastrointestinal hemorrhage
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 129 more
  • neutropenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • decreased motor function
  • tremors
  • speech disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • sensory disturbances
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • hypertension
  • abnormal behavior
  • joint pain
  • myalgia
  • low back pain
  • weight loss
  • weight gain
  • facial flushing
  • weakness
  • rigidity
  • facial edema
  • syncope
  • purpura disease
  • hematochezia
  • thrombocytopenia
  • anemia
  • pneumonia
  • sinusitis
  • visual disturbances
  • visual field defects
  • dry eye syndrome
  • transient blindness
  • congestion
  • tinnitus
  • taste disturbance
  • urination disorders
  • increased urination
  • hypoglycemia
  • hyperuricemia
  • elevated liver enzymes
  • elevated ALT
  • abnormal liver function
  • leg edema
  • arrhythmia
  • bradycardia
  • palpitations
  • contact dermatitis
  • gynecomastia
  • elevated prostate-specific antigen
  • loss of appetite
  • cholecystitis
  • hematemesis
  • spinal hematoma
  • confusion
  • hallucination
  • taste abnormalities
  • taste loss
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • maculopapular rash
  • erythematous skin rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug eruption
  • eczema
  • lichen planus
  • arthritis
  • glomerulonephritis
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased blood creatinine
  • allergic symptoms
  • ischemic necrosis
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • surgical wound hemorrhage
  • pulmonary hemorrhage
  • thrombocytopenia
  • thrombocytopenia
  • leukemia
  • leukopenia
  • eosinophilia
  • menorrhagia
  • hemothorax
  • herpes zoster
  • maculopapular rash
  • urticaria
  • renal function abnormalities
  • acute kidney injury

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.